Salud financiera de hoja de balance de Aarti Drugs
Salud financiera controles de criterios 5/6
Aarti Drugs tiene un patrimonio de accionistas total de ₹12.8B y una deuda total de ₹5.6B, lo que sitúa su ratio deuda-patrimonio en 44%. Sus activos y pasivos totales son ₹24.3B y ₹11.5B respectivamente. El BAIT de Aarti Drugs es de ₹2.5B, por lo que su ratio de cobertura de intereses es de 7.4. Tiene efectivo e inversiones a corto plazo que ascienden a ₹207.7M.
Información clave
44.0%
Ratio deuda-patrimonio
₹5.64b
Deuda
| Ratio de cobertura de intereses | 7.4x |
| Efectivo | ₹207.70m |
| Patrimonio | ₹12.82b |
| Total pasivo | ₹11.50b |
| Activos totales | ₹24.32b |
Actualizaciones recientes sobre salud financiera
Aarti Drugs (NSE:AARTIDRUGS) Has A Somewhat Strained Balance Sheet
Sep 05
Is Aarti Drugs (NSE:AARTIDRUGS) A Risky Investment?
May 04These 4 Measures Indicate That Aarti Drugs (NSE:AARTIDRUGS) Is Using Debt Reasonably Well
Nov 22Does Aarti Drugs (NSE:AARTIDRUGS) Have A Healthy Balance Sheet?
Mar 17Aarti Drugs (NSE:AARTIDRUGS) Seems To Use Debt Quite Sensibly
Dec 08Recent updates
We Discuss Why Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
Sep 20Aarti Drugs (NSE:AARTIDRUGS) Has A Somewhat Strained Balance Sheet
Sep 05Is Aarti Drugs (NSE:AARTIDRUGS) A Risky Investment?
May 04Aarti Drugs Limited Recorded A 9.0% Miss On Revenue: Analysts Are Revisiting Their Models
Feb 01Aarti Drugs (NSE:AARTIDRUGS) Is Due To Pay A Dividend Of ₹1.00
Jan 30Aarti Drugs' (NSE:AARTIDRUGS) Anemic Earnings Might Be Worse Than You Think
May 17These 4 Measures Indicate That Aarti Drugs (NSE:AARTIDRUGS) Is Using Debt Reasonably Well
Nov 22We Take A Look At Why Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO Has Earned Their Pay Packet
Aug 28Here's Why We Think Aarti Drugs (NSE:AARTIDRUGS) Is Well Worth Watching
Aug 19Is Aarti Drugs Limited (NSE:AARTIDRUGS) Expensive For A Reason? A Look At Its Intrinsic Value
May 17Here's Why I Think Aarti Drugs (NSE:AARTIDRUGS) Is An Interesting Stock
Apr 04Does Aarti Drugs (NSE:AARTIDRUGS) Have A Healthy Balance Sheet?
Mar 17Aarti Drugs Limited's (NSE:AARTIDRUGS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 02What Percentage Of Aarti Drugs Limited (NSE:AARTIDRUGS) Shares Do Insiders Own?
Feb 17Why Aarti Drugs Limited (NSE:AARTIDRUGS) Should Be In Your Dividend Portfolio
Feb 04
What Can We Learn About Aarti Drugs' (NSE:AARTIDRUGS) CEO Compensation?
Jan 22Aarti Drugs' (NSE:AARTIDRUGS) Wonderful 432% Share Price Increase Shows How Capitalism Can Build Wealth
Jan 07If You Like EPS Growth Then Check Out Aarti Drugs (NSE:AARTIDRUGS) Before It's Too Late
Dec 23Aarti Drugs (NSE:AARTIDRUGS) Seems To Use Debt Quite Sensibly
Dec 08Aarti Drugs Limited's (NSE:AARTIDRUGS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Nov 23How Much Of Aarti Drugs Limited (NSE:AARTIDRUGS) Do Insiders Own?
Nov 08Here's What We Learned About The CEO Pay At Aarti Drugs Limited (NSE:AARTIDRUGS)
Oct 11Aarti Drugs' (NSE:AARTIDRUGS) Wonderful 514% Share Price Increase Shows How Capitalism Can Build Wealth
Sep 23Aarti Drugs Limited's (NSE:AARTIDRUGS) Business Is Trailing The Market But Its Shares Aren't
Sep 10Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹13.2B) de AARTIDRUGS superan a sus pasivos a corto plazo (₹8.0B).
Pasivo a largo plazo: Los activos a corto plazo de AARTIDRUGS (₹13.2B) superan a sus pasivos a largo plazo (₹3.5B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de AARTIDRUGS (46.6%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de AARTIDRUGS ha pasado de 93.3% a 44% en los últimos 5 años.
Cobertura de la deuda: La deuda de AARTIDRUGS está bien cubierta por el flujo de caja operativo (53.8%).
Cobertura de intereses: Los pagos de intereses de la deuda de AARTIDRUGS están bien cubiertos por el BAIT (8.6x cobertura).